BioValley News

9.10.2012

Clarification on Biosimilar activities

Basel, 05 October 2012 – Following several reports and rumors in the past few days in relation to the Biosimilar activities of the joint venture of Lonza and Teva, Lonza wants to clarify the current situation on...[more]

9.10.2012

Lonza and Celladon Corporation Announce Manufacturing Agreement for MYDICAR®

Agreement will supportfuture clinical trials of Celladon’s product candidate MYDICAR® for the treatment of advanced heart...[more]

9.10.2012

Genzyme Phase 3 Study of Oral Compound Eliglustat Tartrate for Gaucher Disease Meets Primary Endpoint

CAMBRIDGE, Mass., a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that ENGAGE, the first Phase 3 trial of its investigational oral therapy, eliglustat tartrate, in previously untreated patients with Gaucher...[more]

9.10.2012

T-cell vaccine specialist Okairos named by FierceBiotech as one of the 2012 Fierce 15

Basel, Switzerland – 19 September 2012 – FierceBiotech today named Okairos as one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry. This is FierceBiotech's tenth...[more]

4.09.2012

Siegfried Holding AG: Half Year Report

Profitability further enhanced – basis set for continued growthDuring the first half of 2012 the Siegfried Group (SIX: SFZN) successfully maintained revenue growth and increased profitability while progressing with the company...[more]

4.09.2012

mondoBIOTECH holding AG (SIX: RARE) announces today its Half Year Interim Results 2012

Stans, Switzerland, August 29, 2012 - mondoBIOTECH holding AG (SIX: RARE) announces today its Half Year Interim Results 2012General OverviewThe Group has not generated revenue in the half year ending 30 June 2012 (as in 2011 1H),...[more]

4.09.2012

Novozymes and Terranol to market advanced biofuel yeast

Partners aim to accelerate the development of C5 yeast to ensure fast commercialization of advanced biofuels made from agricultural waste, energy crops and other types of biomass.[more]

28.08.2012

Genzyme Provides Update on U.S. LEMTRADA™ Filing

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced it has received a Refuse to File letter from the U.S. Food and Drug Administration (FDA) in response to the supplemental...[more]

27.08.2012

Straumann reports stable net revenues of CHF 362 million in first half of 2012

Basel, 21 August 2012: The Straumann Group today reported first-half net revenues of CHF 362 million, matching the prior year’s comparative level in local currencies. In Swiss francs, net revenue dipped slightly less than 2%,...[more]

7.08.2012

Galapagos delivers solid half year results 2012

• Group revenues €64.5 M compared to €39.7 M in H1 2011 (+62%)• Group net loss €11.3 M compared to €27.7 M loss last year• Cash position of €122.6 M on 30 June 2012• Service division external revenues €32.9 M compared to €24 M...[more]

Displaying results 41 to 50 out of 1827

< Previous

1

2

3

4

5

6

7

8

9

10

Next >